Epic Build / Desired Build Test Compendium
Welcome to the new Northwell Health Labs Epic Build / Desired Build Test Directory! Please email ClinicalLabInformatics@northwell.edu with any typos, corrections or issues.

Atypical Hemolytic Uremic Syndrome (AHUS) Complement Panel

Desired Epic Build * = editable field  

Cerner Primary Mnemonic: aHUS Complement Panel, S and P
PDM 225440
Informatics - WorkgroupHematology
Synonyms *
Display Name *Atypical Hemolytic Uremic Syndrome (AHUS) Complement Panel
Specimen Sources (combined Order Entry and Specimen Navigator) *
Specimen Types (combined Order Entry and Specimen Navigator) *
Blood
Body Fluids (types sent through AOEs)
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis ORDERING GUIDANCE This test should be performed prior to treatment initiation and in the absence of therapy with complement inhibitors, such as eculizumab or ravulizumab. Complement inhibitors will affect performance of these assays. For evaluating patients with possible thrombotic microangiopathies (TMA), the recommended first-tier test is ADM13 / ADAMTS13 Activity and Inhibitor Profile, Plasma. This test should be a second-tier test for TMA. For patients who have received eculizumab or need to monitor response to eculizumab therapy, the recommended test is ECUMP / Eculizumab Monitoring Panel, Serum. Soluble membrane attack complex (sMAC) should not be used as a standalone assay to monitor eculizumab efficiency.
IP Orderable (inpatient) Yes
OP Orderable (outpatient) Yes
AOEs *

AOE PDM AOE Display AOE Description Prompt
AOE225440B AHUSEOR Is Eculizumab or Ravulizumab taken? X
AP AOEs
Special History No
Build Comments
Filter *
Cerner Site RestrictMayo Medical Labs
Cerner Results

Result Desc Result display Result PDM
Factor B Complement Antigen, S FBCOMAS 225440G
Complement C3, S COMC3S 225440E
Complement C4, S COMC4S 225440F
Factor H Complement Antigen, S FHCOMAS 225440H
Alternative Complement Path Func, S ALTCOMFS 225440D
Is Eculizumab or Ravulizumab taken? AHUSEOR 225440B
CBb Complement, P CBDCOMP 225440J
AHUS Interpretation AHUSINT 225440A
Complement, Total, S COMPTOTS 225440C
SC5b-9 Complement, P SC5B9CP 225440K

Actual Epic Build 3/11/2025

PROCEDURE ID 114482
PDM 225440
ORDER DISPLAY NAME Atypical Hemolytic Uremic Syndrome (AHUS) Complement Panel
PROCEDURE NAME ATYPICAL HEMOLYTIC UREMIC SYNDROME COMPLEMENT P
PROCEDURE MASTER NUMBER LAB11038
SHORT PROCEDURE NAME ATYPICAL HEMOLYTIC UREMIC SYNDROME COMPLEMENT P
CATEGORY CODE 1.0
CATEGORY CODE RECORD NAME LAB BLOOD ORDERABLES
SYNONYMS
CLINICALLY ACTIVE Yes
ORDERABLE Yes
PERFORMABLE Yes
FILTER GENOMICS
REFERENCE LINK URL https://labs.northwell.edu/epic/test/114482
ORDERING INSTRUCTIONS
DEFAULT SPECIMEN TYPE Blood
SPECIMEN TYPE PICK LIST Blood
SPECIMEN TYPE LIST
OP SPECIMEN TYPE LIST
SPECIMEN SOURCE PICK LIST Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
SPECIMEN SOURCE DEFAULT - MALE Blood, Venous
SPECIMEN SOURCE DEFAULT - FEMALE Blood, Venous
SPECIMEN SOURCE LIST
OP SPECIMEN SOURCE LIST
IP LAB TEST COMPONENTS FOR REPORT AHUSINT
MEDTAKEN
COMTOTS
ALTCOMPPATH
C3COMP
C4COMP
FACTORB
FACTORH
CBBCOMP
SC5B9CO
OP LAB TEST COMPONENTS FOR REPORT AHUSINT
MEDTAKEN
COMTOTS
ALTCOMPPATH
C3COMP
C4COMP
FACTORB
FACTORH
CBBCOMP
SC5B9CO
ORDER QUESTIONS ["3046000027"]
ORDER QUESTIONS RECORD NAME NH IP AHUSEOR
INPATIENT ORDER QUESTIONS ["3046000027"]
INPATIENT ORDER QUESTIONS RECORD NAME NH IP AHUSEOR
ORDER SPECIFIC QUESTION OVERRIDE
INPATIENT QUESTION OVERRIDE
LOCATION RESTRICT LIST IP
LOCATION RESTRICT LIST IP RECORD NAME
LOCATION RESTRICT LIST INCLUDE IP
LOCATION RESTRICT LIST OP
LOCATION RESTRICT LIST OP RECORD NAME
LOCATION RESTRICT LIST INCLUDES OP
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP SPECIMEN SOURCE Blood, Venous
Blood, Central Line
Blood, Arterial
Blood, Capillary
EDP OP SPECIMEN SOURCE
EDP IP SPECIMEN TYPE Blood
EDP OP SPECIMEN TYPE
DERIVED EDP IP BUTTONS S Blood, Central Line
Blood, Arterial
Blood, Capillary
Blood, Venous
DERIVED EDP IP BUTTONS T Blood
DERIVED EDP OP BUTTONS S
DERIVED EDP OP BUTTONS T
IP ORDERABLE 1
OP ORDERABLE 1
STANDARD LAB COMPONENTS
STANDARD LAB COMPONENTS RECORD NAME
COMPONENT DATA REQUIREMENT
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3046000027 NH IP AHUSEOR Is Eculizumab or Ravulizumab taken? Custom List Yes
No
Yes
EPIC IP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3046000027 NH IP AHUSEOR Is Eculizumab or Ravulizumab taken? Custom List Yes
No
Yes
EPIC Components (results - crosswalked through Cerner)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047802388.0 FACTOR B COMPLEMENT ANTIGEN, S FACTORB FACTOR B COMPLEMENT ANTIGEN, S 225440G
3047801953.0 COMPLEMENT C3, S C3COMP COMPLEMENT C3, S 225440E
3047801954.0 COMPLEMENT C4, S C4COMP COMPLEMENT C4, S 225440F
3047802389.0 FACTOR H COMPLEMENT ANTIGEN, S FACTORH FACTOR H COMPLEMENT ANTIGEN, S 225440H
3047800975.0 ALTERNATIVE COMPLEMENT PATH FUNC, S ALTCOMPPATH ALTERNATIVE COMPLEMENT PATH FUNC, S 225440D
3047803109.0 IS ECULIZUMAB OR RAVULIZUMAB TAKEN? MEDTAKEN IS ECULIZUMAB OR RAVULIZUMAB TAKEN 225440B
3047801681.0 CBB COMPLEMENT, P CBBCOMP CBB COMPLEMENT, P 225440J
3047800899.0 ATYPICAL HEMOLYTIC UREMIC SYNDROME INTERPRETATION AHUSINT ATYPICAL HEMOLYTIC UREMIC SYNDROME INTERPRETATION 225440A
3047801956.0 COMPLEMENT, TOTAL, S COMTOTS COMPLEMENT, TOTAL, S 225440C
3047804663.0 SC5B-9 COMPLEMENT, P SC5B9CO SC5B 9 COMPLEMENT, P 225440K